Efficacy and Effectiveness Outcomes of Treatments for Double‐Exposed Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma Patients: A Systematic Literature Review

Efficacy and Effectiveness Outcomes of Treatments for Double‐Exposed Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma Patients: A Systematic Literature Review

ABSTRACT Background Bruton's tyrosine kinase inhibitors (BTKi) and the B‐cell lymphoma 2 (BCL2) inhibitor venetoclax have significantly improved outcomes and achieved durable remission in patients with chronic lymphocytic leukemia (CLL). BTKi/venetoclax‐treated patients with exposure to both no...

Full description

Saved in:
Bibliographic Details
Main Authors: Mohammed Zuber, Sreelatha Akkala, Niying Li, Sajesh K. Veettil, Chia Jie Tan, Lorenzo Villa Zapata
Format: Article
Language:English
Published: Wiley 2024-09-01
Series:Cancer Medicine
Subjects:
BTKi
chronic lymphocytic leukemia
double exposed
double refractory
efficacy
relapsed/refractory
Online Access:https://doi.org/10.1002/cam4.70258
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/cam4.70258

Similar Items